Hagan H - Search Results

1

Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.

Hagan H, Thiede H, Des Jarlais DC. Hagan H, et al. Epidemiology. 2004 Sep;15(5):543-9. doi: 10.1097/01.ede.0000135170.54913.9d. Epidemiology. 2004. PMID: 15308953

2

The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.

Strauss SM, Astone JM, Hagan H, Des Jarlais DC. Strauss SM, et al. Among authors: hagan h. J Urban Health. 2004 Mar;81(1):38-47. doi: 10.1093/jurban/jth086. J Urban Health. 2004. PMID: 15047782 Free PMC article.

3

Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.

Astone JM, Strauss SM, Hagan H, Des Jarlais DC. Astone JM, et al. Among authors: hagan h. Am J Drug Alcohol Abuse. 2004 Nov;30(4):783-97. doi: 10.1081/ada-200037544. Am J Drug Alcohol Abuse. 2004. PMID: 15624549

4

Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.

Strauss SM, Astone JM, Des Jarlais DC, Hagan H. Strauss SM, et al. Among authors: hagan h. AIDS Patient Care STDS. 2005 Feb;19(2):78-88. doi: 10.1089/apc.2005.19.78. AIDS Patient Care STDS. 2005. PMID: 15716639

5

Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.

Hagan H, Strauss SM, Astone JM, Des Jarlais DC. Hagan H, et al. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S297-303. doi: 10.1086/427444. Clin Infect Dis. 2005. PMID: 15768338

6

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

Hagan H, Thiede H, Des Jarlais DC. Hagan H, et al. AIDS. 2005 Oct;19 Suppl 3:S199-207. doi: 10.1097/01.aids.0000192090.61753.d4. AIDS. 2005. PMID: 16251818 Review.

7

Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.

Strauss SM, Rindskopf DM, Astone-Twerell JM, Des Jarlais DC, Hagan H. Strauss SM, et al. Among authors: hagan h. Drug Alcohol Depend. 2006 Jun 9;83(1):15-24. doi: 10.1016/j.drugalcdep.2005.10.005. Epub 2005 Nov 9. Drug Alcohol Depend. 2006. PMID: 16289523

8

Hepatitis C knowledge among staff in U.S. drug treatment programs.

Strauss SM, Astone-Twerell JM, Munoz-Plaza C, Des Jarlais DC, Gwadz M, Hagan H, Osborne A, Rosenblum A. Strauss SM, et al. Among authors: hagan h. J Drug Educ. 2006;36(2):141-58. doi: 10.2190/3EMQ-N350-W4XN-WT1X. J Drug Educ. 2006. PMID: 17153514

9

Non-injection drug use and Hepatitis C Virus: a systematic review.

Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, Strauss S. Scheinmann R, et al. Among authors: hagan h. Drug Alcohol Depend. 2007 Jun 15;89(1):1-12. doi: 10.1016/j.drugalcdep.2006.11.014. Epub 2006 Dec 15. Drug Alcohol Depend. 2007. PMID: 17174481 Free PMC article. Review.

10

Self-reported hepatitis C virus antibody status and risk behavior in young injectors.

Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS. Hagan H, et al. Public Health Rep. 2006 Nov-Dec;121(6):710-9. doi: 10.1177/003335490612100611. Public Health Rep. 2006. PMID: 17278406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters